{"transactions":[{"id":771754,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":45967,"kind":"person","name":"Angelov Angel S","position":1,"cik":"0002132062","reported_name":"Angelov Angel S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-19T20:52:17.000Z","date":"2026-05-18","kind":"grant","planned":false,"acquired":true,"shares":150000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The stock options were granted in connection with the Reporting Person's appointment as Chief Medical Officer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the stock options vest on May 18, 2027  (the \"Vesting Start Date\") and 1/36th of the remaining number of shares vest monthly thereafter until all awarded shares are fully vested three (3) years after the Vesting Start Date."}],"balance_after":150000,"derivative":{"exercise_price":0.5955,"expiration_date":"2036-05-18","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0002132062-26-000004","document":"form4-05192026_080513.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000213206226000004/form4-05192026_080513.xml","form_type":"4"}}]}